1. Home
  2. NXJ vs TRDA Comparison

NXJ vs TRDA Comparison

Compare NXJ & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXJ
  • TRDA
  • Stock Information
  • Founded
  • NXJ 1999
  • TRDA 2016
  • Country
  • NXJ United States
  • TRDA United States
  • Employees
  • NXJ N/A
  • TRDA N/A
  • Industry
  • NXJ Finance/Investors Services
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXJ Finance
  • TRDA Health Care
  • Exchange
  • NXJ Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • NXJ 492.3M
  • TRDA 502.9M
  • IPO Year
  • NXJ N/A
  • TRDA 2021
  • Fundamental
  • Price
  • NXJ $11.70
  • TRDA $9.56
  • Analyst Decision
  • NXJ
  • TRDA Strong Buy
  • Analyst Count
  • NXJ 0
  • TRDA 3
  • Target Price
  • NXJ N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • NXJ 74.9K
  • TRDA 110.4K
  • Earning Date
  • NXJ 01-01-0001
  • TRDA 05-06-2025
  • Dividend Yield
  • NXJ 3.27%
  • TRDA N/A
  • EPS Growth
  • NXJ N/A
  • TRDA N/A
  • EPS
  • NXJ N/A
  • TRDA 1.68
  • Revenue
  • NXJ N/A
  • TRDA $210,782,000.00
  • Revenue This Year
  • NXJ N/A
  • TRDA N/A
  • Revenue Next Year
  • NXJ N/A
  • TRDA N/A
  • P/E Ratio
  • NXJ N/A
  • TRDA $5.69
  • Revenue Growth
  • NXJ N/A
  • TRDA 63.38
  • 52 Week Low
  • NXJ $10.06
  • TRDA $9.51
  • 52 Week High
  • NXJ $12.24
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • NXJ 28.35
  • TRDA 30.19
  • Support Level
  • NXJ $11.66
  • TRDA $9.75
  • Resistance Level
  • NXJ $11.96
  • TRDA $10.87
  • Average True Range (ATR)
  • NXJ 0.10
  • TRDA 0.53
  • MACD
  • NXJ -0.02
  • TRDA -0.00
  • Stochastic Oscillator
  • NXJ 10.00
  • TRDA 2.70

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: